Fig. 3From: The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort studyHazard rates of neutropenic events related to hazard rates of measures implemented to avoid neutropenic complications.Back to article page